Navigation Links
Hospira Names Matthew R. Stober Senior Vice President of Operations
Date:4/15/2013

LAKE FOREST, Ill., April 15, 2013 /PRNewswire/ -- Hospira, Inc. (NYSE: HSP), the world's leading provider of injectable drugs and infusion technologies, announced that Matthew R. (Matt) Stober has been named senior vice president, Operations, effective today. In addition to expanding his current U.S. responsibilities to assume leadership for all of Hospira's pharmaceutical manufacturing operations, Mr. Stober will have responsibility for the operations functions, including manufacturing science and technology, engineering, competitive strategy, health and safety, supply chain and procurement. Mr. Stober succeeds John B. Elliot , who has led the Operations organization since April 2012 and will provide continuity of support until his retirement at the end of the year. Both Mr. Elliot and Mr. Stober will serve as members of the company's senior leadership team, led by F. Michael Ball , chief executive officer.

"Matt brings the perfect blend of vision and experience to our operations organization, backed by a proven track record of success at Hospira," said Mr. Ball. "In his expanded role, we're confident Matt will continue to successfully advance our dual commitment to remediate and modernize our processes and operations while delivering patient-critical products, and ultimately establish our manufacturing operations as a strategic, competitive advantage. We thank John for his strong counsel and continued support during the transition and look forward to Matt's many additional contributions."  

Mr. Stober, 45, joined Hospira in 2011 as its corporate vice president, U.S. Pharma Operations, where he has held primary responsibility for Hospira's Rocky Mount, N.C.; McPherson, Kan.; Austin, Texas; and Clayton, N.C., facilities, along with global engineering and program management. In 2012, he supported Hospira's efforts to produce and deliver more than half a billion units that were on the U.S. Food and Drug Administration (FDA) drug shortage list to help alleviate the industry-wide shortage for critical generic injectable drugs.

He joined Hospira from Johnson & Johnson, where he served as the vice president and global platform leader for solids, parenterals and vaccines. Mr. Stober has extensive experience managing transformational change in business-critical settings, as well as leading global and multi-company development projects, new product launches and large-scale organizational transformations. He has been in the pharmaceutical industry for nearly 25 years, having held significant leadership roles at Novartis Vaccines and Diagnostics, GlaxoSmithKline and Merck.

Born in Connecticut, Mr. Stober earned his Bachelor of Science degree in chemical engineering from Villanova University.

About Hospira
Hospira, Inc. is the world's leading provider of injectable drugs and infusion technologies. Through its broad, integrated portfolio, Hospira is uniquely positioned to Advance Wellness™ by improving patient and caregiver safety while reducing healthcare costs. The company is headquartered in Lake Forest, Ill., and has approximately 16,000 employees. Learn more at www.hospira.com.


'/>"/>
SOURCE Hospira, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Hospira to Host Conference Call for First-Quarter 2013 Results
2. Hospira Announces Executive Changes
3. Hospira Reports Fourth-Quarter and Full-Year 2012 Results
4. Hospira to Present at Upcoming Investor Conferences
5. Hospira and Q Core Medical Sign International Distribution Agreement for Sapphire Infusion System
6. Hospira to Present at the J.P. Morgan 31st Annual Healthcare Conference Jan. 8, 2013
7. Hospira Reports Third-Quarter 2012 Results
8. Hospira to Acquire Active Pharmaceutical Ingredient Manufacturing and R&D Facilities
9. Hospira Reports Second-Quarter 2012 Results
10. Hospira Expands Board of Directors With Election of Dennis M. Fenton
11. Hospira to Host Conference Call for Second-quarter 2012 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2017)...  A recent study published in the American ... as a means of disinfection anesthesia workstations ... on anesthesia workstations. In the study, UVC disinfection ... equipment surfaces contaminated with three (3) organisms commonly ... further validates the body of literature supporting Tru-D," ...
(Date:5/4/2017)...  DarioHealth Corp. (NASDAQ: DRIO), a leading global digital ... today announced that it is teaming up with Auto ... to lower diabetes healthcare costs in Canada ... is available throughout all provinces and territories in ... for additional savings when shopping for Dario supplies in ...
(Date:5/3/2017)... Calif. , May 3, 2017 ... of any hospital or healthcare facility. Commonly referred ... room is equipped with diagnostic imaging technology to ... of the heart. In these spaces, a team ... catheterization, balloon angioplasty, percutaneous coronary intervention, congenital heart ...
Breaking Medicine Technology:
(Date:5/26/2017)... (PRWEB) , ... May 26, 2017 , ... ... gather at Boston CEO 2017 on May 30th and 31st at The Four ... forum for leading executives in the life sciences, offering exclusive access to key ...
(Date:5/26/2017)... ... ... A new analysis of community health data reveals that four out of ... With the average cost of healthcare rising and the U.S. senior population expected to ... affordability of where they live. An annual 2017 report looked at a variety of ...
(Date:5/26/2017)... ... May 26, 2017 , ... After raising nearly $30,000 on ... will continue to be available at a discounted crowdfunding price on Indiegogo . ... they are, I also wanted to bring a fidget toy to the market that ...
(Date:5/26/2017)... ... May 26, 2017 , ... Dr. Alex Rabinovich, a highly-skilled ... a new, informational blog post on insurance options. If a Bay Area patient has ... help save time and money. Visiting an in-network provider for a second opinion can ...
(Date:5/26/2017)... ... ... of Eden”: retells the stories of three Bible figures in modern terms. “Just What ... trader, horse farmer, artist and a former GM journeyman. Born in 1953 in Portland, ... to Dayton, Ohio, where Penny graduated high school. At sixteen, she toured France to ...
Breaking Medicine News(10 mins):